Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
No data available for this stock.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Insmed Incorporated NASDAQ:INSM | $26.58B | $121.16 | Not rated | -17.4 | -41.15% |
MannKind Corporation NASDAQ:MNKD | $1.33B | $4.13 | Overvalued | -50.3 | -18.60% |
Gyre Therapeutics, Inc. NASDAQ:GYRE | $471.74M | $4.31 | Overvalued | -88.3 | -42.67% |
Vicore Pharma Holding AB NASDAQ:VCRE | $292.65M | $10.36 | Not rated | — | — |
Continue the stock analysis
Jump to another research area for this company.